Treatment strategies for alopecia (Q56991024)

Expert Opinion on Pharmacotherapy

Europe PubMed Central

title

Treatment strategies for alopecia (English)

0 references

author name string

Antonella Tosti

series ordinal

1

0 references

Bruna Duque-Estrada

series ordinal

2

0 references

language of work or name

English

0 references

publication date

April 2009

0 references

published in

0 references

volume

10

0 references

issue

6

0 references

page(s)

1017-26

0 references

cites work

Minoxidil: mechanisms of action on hair growth

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Medical treatments for male and female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo, or no treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Allergic contact dermatitis to topical minoxidil solution: etiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Finasteride in the treatment of men with frontal male pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

The influence of finasteride on the development of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Female pattern hair loss, sebum excretion and the end-organ response to androgens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Finasteride treatment of female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Effect of finasteride 5 mg (Proscar) on acne and alopecia in female patients with normal serum levels of free testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Susceptibility variants for male-pattern baldness on chromosome 20p11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

21 January 2018

Alopecia areata update

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Guidelines for the management of alopecia areata

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Efficacy of betamethasone valerate foam formulation in comparison with betamethasone dipropionate lotion in the treatment of mild-to-moderate alopecia areata: a multicenter, prospective, randomized, controlled, investigator-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Patients at risk of onychomycosis--risk factor identification and active prevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Pulse corticosteroid therapy for alopecia areata: study of 139 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

The use of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia totalis or universalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Is topical tacrolimus effective in alopecia areata universalis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Cicatricial alopecia: classification and histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Lichen planopilaris: report of 30 cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Management of primary cicatricial alopecias: options for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Lichen planopilaris. Successful treatment with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Thalidomide-induced remission of lichen planopilaris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Low molecular weight heparin; a novel alternative therapeutic approach for lichen planus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Frontal fibrosing alopecia: a survey in 16 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Frontal fibrosing alopecia in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Update on primary cicatricial alopecias

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Cicatricial alopecia: discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Treatment of cutaneous lupus erythematosus with acitretin and hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Thalidomide: dermatological indications, mechanisms of action and side-effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

21 January 2018

Folliculitis decalvans

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Folliculitis decalvans including tufted folliculitis: clinical, histological and therapeutic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Intramuscular immunoglobulin for recalcitrant suppurative diseases of the skin: a retrospective review of 63 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Association of androgenetic alopecia with smoking and its prevalence among Asian men: a community-based survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368

Is androgenetic alopecia a photoaggravated dermatosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560902876368